Gene Medicine

Reforgene Medicine develops gene editing therapies for genetic diseases and diseases with major unmet need, focusing on innovative treatments using CRISPR/Cas technology

Biotech & Life Sciences

Sector

Seed

Stage

Biotech

Model

01Company Overview

Reforgene Medicine develops gene editing therapies for genetic diseases and diseases with major unmet need, focusing on innovative treatments using CRISPR/Cas technology.

02Backed By1 investor

IIIMM Investment→

03Similar Companies